Study for Stargardt Disease and ABCA4 Mutations

Prescreening Study to Identify Potential Stargardt Participants for ACDN-01 Clinical Trials (STARPATH)

Recruiting Observational Study
Stargardt Disease Stargardt Disease 1 Cone Rod Dystrophy Juvenile Macular Degeneration
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
5 and older
Sex
Any
Study type
Observational
Participants needed
50 (estimated)
Sponsor
Ascidian Therapeutics, Inc · Industry
Who this trial is looking for

This trial is looking for individuals with specific genetic mutations related to Stargardt disease. Participants will undergo tests to see if they qualify for further clinical trials.

Are You a Good Fit for This Trial?

You may be able to join if

  • I have mutations in the ABCA4 gene
  • I have been diagnosed with Stargardt disease type 1 or cone-rod dystrophy

You may not be able to join if

  • I have mutations in other genes that cause cone-rod dystrophy or Stargardt disease
  • I have another type of retinal disease unrelated to ABCA4
  • I have a medical condition that might make it unsafe for me to participate
  • I have a psychiatric condition or substance abuse disorder

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial

This is an observational prescreening study. Individuals who are eligible for prescreening will undergo testing procedures that may be used to determine eligibility in ACDN-01 clinical trials.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Key Inclusion Criteria: * Presence of mutations in the ABCA4 gene * ABCA4 retinopathy phenotype (Stargardt disease type 1 or cone-rod dystrophy) Key Exclusion Criteria: * The presence of pathogenic or likely pathogenic mutations in other genes known to cause cone-rod dystrophy or Stargardt maculo…
Contacts

Senior Clinical Trial Manager

207-573-0412

researchtrials@ascidian-tx.com

CONTACT